Alvogen’s Lotus Bags $50m Investment To Boost Access In Asia
Taiwan-Based Company Issues 17m New Shares
Lotus Pharmaceuticals aims to build a stronghold in Thailand and beyond, after the Alvogen subsidiary announced a partnership with a subsidiary of Thai state-owned conglomerate PTT, which includes a $50m capital injection.